Answers are grounded in this paper and cite their sources.
In conclusion, this meta-analysis indicated that metformin may be a useful adjuvant agent for gynecological cancer with DM, especially for patients with ovarian cancer and endometrial cancer.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: